Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
COPENHAGEN, Denmark, August 25, 2026 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.
|
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||
|
a) |
Name |
Paul Chaplin |
|
|
2. |
Reason for the notification |
||
|
a) |
Position/status |
President and Chief Executive Officer of Bavarian Nordic A/S |
|
|
b) |
Initial notification/Amendment |
Initial notification |
|
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
|
a) |
Name |
Bavarian Nordic A/S |
|
|
b) |
LEI |
2138006JCDVYIN6INP51 |
|
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Shares
|
|
|
b) |
Nature of the transaction |
Sale |
|
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
|
|
DKK 212.4214 |
90,000 |
|
d) |
Aggregated information - Aggregated volume - Price |
90,000 DKK 19,117,925.90 |
|
|
e) |
Date of the transaction |
2026-08-24 |
|
|
f) |
Place of the transaction |
Nasdaq Copenhagen A/S, XCSE |
|
|
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||
|
a) |
Name |
Maria Tzatzaris |
|
|
2. |
Reason for the notification |
||
|
a) |
Position/status |
Closely associated with Paul Chaplin, President and Chief Executive Officer of Bavarian Nordic A/S |
|
|
b) |
Initial notification/Amendment |
Initial notification |
|
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
|
a) |
Name |
Bavarian Nordic A/S |
|
|
b) |
LEI |
2138006JCDVYIN6INP51 |
|
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Shares
|
|
|
b) |
Nature of the transaction |
Sale |
|
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
|
|
DKK 207.91 |
14,840 |
|
d) |
Aggregated information - Aggregated volume - Price |
14,840 DKK 3,085,384.40 |
|
|
e) |
Date of the transaction |
2026-08-21 |
|
|
f) |
Place of the transaction |
Nasdaq Copenhagen A/S, XCSE |
|
About Bavarian Nordic
Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. For more information, visit www.bavarian-nordic.com
Contact investors:
Anders Hjort, Head of Investor Relations, ahjo@bavarian-nordic.com, Tel: +45 44 74 99 58
Graham Morrell, Gilmartin Group, graham@gilmartinir.com, Tel: +1 781 686 9600
Contact media:
Isabel Hagbrink, Head of Media Relations, isha@bavarian-nordic.com, Tel: +45 71 79 67 33
Company Announcement no. 37 / 2026